Apyx Medical Corp. (APYX) Tops Q2 EPS by 2c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.32 million.

GUIDANCE:

Apyx Medical Corp. sees FY2026 revenue of $59-60 million, versus the consensus of $59.55 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Catalyst Metals Ltd (CYL:AU) PT Lowered to AUD9.25 at UBS